CARLSBAD, Calif., June 17,
2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc.
(Nasdaq: IONS) today announced that management will participate in
a fireside chat at the virtual TD Cowen Genetic Medicines & RNA
Summit on Thursday, June 20,
2024.
A live webcast of this presentation can be accessed on the
Investors & Media section of the Ionis website at
https://ir.ionis.com/events-and-presentations/upcoming-events. A
replay will be available on the Ionis website within 48 hours and
will be archived for a limited time.
About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better
futures to people with serious diseases. Ionis currently has five
marketed medicines and a leading pipeline in neurology, cardiology,
and other areas of high patient need. As the pioneer in
RNA-targeted medicines, Ionis continues to drive innovation in RNA
therapies in addition to advancing new approaches in gene editing.
A deep understanding of disease biology and industry-leading
technology propels our work, coupled with a passion and urgency to
deliver life-changing advances for patients.
To learn more about Ionis, visit Ionis.com and follow us on X
(Twitter) and LinkedIn.
Ionis Pharmaceuticals Investor Contact:
D.
Wade Walke, Ph.D. –
ir@ionis.com – 760-603-2331
Ionis Pharmaceuticals Media Contact:
Hayley Soffer – media@ionis.com –
760-603-4679
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-td-cowen-genetic-medicines--rna-summit-302174669.html
SOURCE Ionis Pharmaceuticals, Inc.